Mobile  |  About us  |  Photos  |  Videos  |  Subscriptions  |  RSS Feeds  |  Today's Paper  |  Classifieds  |  Contact Us
The Daily Star
WEDNESDAY, 23 APR 2014
06:52 PM Beirut time
Weather    
Beirut
23 °C
Blom Index
BLOM
1,214.01down
Lebanon News
Follow this story Print RSS Feed ePaper share this
Cancer medication double global price in Lebanon
Nexavar (R) (sorafenib) tablets received U.S. FDA approval for the treatment of patients with advanced kidney cancer.  (PRNewsFoto/Bayer Pharmaceuticals Corporation and Onyx Pharmaceuticals, Inc.)
Nexavar (R) (sorafenib) tablets received U.S. FDA approval for the treatment of patients with advanced kidney cancer. (PRNewsFoto/Bayer Pharmaceuticals Corporation and Onyx Pharmaceuticals, Inc.)
A+ A-

BEIRUT: A source close to the Health Ministry confirmed that the price of a vital cancer medication in Lebanon is approximately twice what it is abroad, but defended the markup on economic grounds.

“Of course the country should profit,” said Mohammad Yassin, an adviser to caretaker Health Minister Ali Hasan Khalil, commenting on a report that first appeared in As-Safir newspaper.

“The local price of the medicine depends on the initial price set by the company, including import taxes and shipping costs,” he added. “Naturally, the price will go up.”

The drug in question, Nexavar, is used in the treatment of thyroid and other cancers and is manufactured in Germany by Bayer. The local price, which was confirmed by local pharmacists, is $3,735 for a pack of 60 tablets. According to As-Safir, the same pack would sell for $1,860 in the United States. In most cases, a thyroid cancer patient would need two packets a month, totaling $7,470.

The price of medication in Lebanon is determined by the Health Ministry in coordination with the manufacturer, the ministry’s general director, Fouad Fleifil, confirmed.

But a lawyer for Consumers Lebanon said even taking into account the cost of shipping, taxes and profits for distributors and pharmacists, the profit margin was far too high to be ethical.

“We do not go public with a topic unless we have done all the investigation necessary about this issue and spoken to the authorities,” Mohammad Darwish said.

“We have already sent a letter to the company demanding some answers, but we received a vague response,” he said, adding that the advocacy group was preparing to file a lawsuit against the company.

Multiple pharmacies in Beirut said the medication was expensive and rarely kept in stock, but could be ordered by customer request.

“It is too expensive to always be available,” said Mohammad Abbas, a pharmacist at Al-Sahel Pharmacy. “The patient must pay a deposit, then we request it from the distributor.”

According to the Health Ministry’s website, the only company licensed to import the medicine is Droguerie R. Pharaon & Fils S.A.L

Armand Phares, president of the Lebanese Pharmaceuticals Importers Association, is also Droguerie R. Pharaon & Fils' agent.

“We do not interfere personally with price determination,” he said.

He confirmed that the price was set by the ministry in accordance with Lebanese law.

Darwish admitted that, while it was natural for the price in Lebanon to be slightly higher than it would be abroad, such a gap was unacceptable.

“This medicine can cure cancer and is capable of saving hundreds of lives. That should be given priority.”

 
A version of this article appeared in the print edition of The Daily Star on February 01, 2014, on page 3.
Home Lebanon News
 
     
 
Lebanon
Advertisement
Comments  

Your feedback is important to us!

We invite all our readers to share with us their views and comments about this article.

Disclaimer: Comments submitted by third parties on this site are the sole responsibility of the individual(s) whose content is submitted. The Daily Star accepts no responsibility for the content of comment(s), including, without limitation, any error, omission or inaccuracy therein. Please note that your email address will NOT appear on the site.

comments powered by Disqus
Story Summary
A source close to the Health Ministry confirmed that the price of a vital cancer medication in Lebanon is approximately twice what it is abroad, but defended the markup on economic grounds.

The local price, which was confirmed by local pharmacists, is $3,735 for a pack of 60 tablets.

The price of medication in Lebanon is determined by the Health Ministry in coordination with the manufacturer, the ministry's general director, Fouad Fleifil, confirmed.

According to the Health Ministry's website, the only company licensed to import the medicine is Droguerie R. Pharaon & Fils S.A.L

Darwish admitted that, while it was natural for the price in Lebanon to be slightly higher than it would be abroad, such a gap was unacceptable.
Related Articles
 
 
Medication costs to be slashed by a quarter
 
 
Abu Faour announces new drug price reductions
 
 
Drug industry insiders allege dubious practices in sector
More from
Rasha Fattouh
 
 
Casino Du Liban gets a taste of Puglia
 
 
Inventor hopes to incinerate Lebanon’s trash woes
 
 
Young athlete’s tragic death gives rise to ‘Young Heart’ foundation
 
 
Decline of Arabic ‘failure of politics’
Entities
Advertisement


Baabda 2014
Advertisement
Follow us on Facebook Follow us on Twitter Follow us on Linked In Follow us on Google+ Subscribe to our Live Feed
Multimedia
Images  
Pictures of the day
A selection of images from around the world- Wednesday, April 23, 2014
View all view all
Advertisement
Rami G. Khouri
Rami G. Khouri
Israel shows Zionism’s true colors
Michael Young
Michael Young
Why confuse gibberish with knowledge?
David Ignatius
David Ignatius
Echoes of 1914 characterize the Ukraine crisis
View all view all
Advertisement
cartoon
 
Click to View Articles
 
 
News
Business
Opinion
Sports
Culture
Technology
Entertainment
Privacy Policy | Anti-Spamming Policy | Disclaimer | Copyright Notice
© 2014 The Daily Star - All Rights Reserved - Designed and Developed By IDS